TETRAPHASE PHARMACEUTICALS INC Forms 3, 4 and 5: Preferred Stock
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 105 rows in 2013. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2013-03-25: Reporting owner CMEA Ventures VI Management, L.P. | Handelsman Karl D. | Watson James F | CMEA Ventures VI GmbH & Co. KG | Collier David J | CMEA VENTURES VI LP | BARUCH THOMAS R | Sohail Faysal A.; Form 4; Security Series A-1 Convertible Participating Preferred Stock; Transaction C Conversion of derivative security.
- 2013-03-25: Reporting owner CMEA Ventures VI Management, L.P. | Handelsman Karl D. | Watson James F | CMEA Ventures VI GmbH & Co. KG | Collier David J | CMEA VENTURES VI LP | BARUCH THOMAS R | Sohail Faysal A.; Form 4; Security Series A-1 Convertible Participating Preferred Stock; Transaction C Conversion of derivative security.
- 2013-03-25: Reporting owner CMEA Ventures VI Management, L.P. | Handelsman Karl D. | Watson James F | CMEA Ventures VI GmbH & Co. KG | Collier David J | CMEA VENTURES VI LP | BARUCH THOMAS R | Sohail Faysal A.; Form 4; Security Series A-2 Convertible Participating Preferred Stock; Transaction C Conversion of derivative security.
- 2013-03-25: Reporting owner CMEA Ventures VI Management, L.P. | Handelsman Karl D. | Watson James F | CMEA Ventures VI GmbH & Co. KG | Collier David J | CMEA VENTURES VI LP | BARUCH THOMAS R | Sohail Faysal A.; Form 4; Security Series A-2 Convertible Participating Preferred Stock; Transaction C Conversion of derivative security.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2013-03-25 | CMEA Ventures VI Management, L.P. | Handelsman Karl D. | Watson James F | CMEA Ventures VI GmbH & Co. KG | Collier David J | CMEA VENTURES VI LP | BARUCH THOMAS R | Sohail Faysal A. 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Series A-1 Convertible Participating Preferred Stock Derivative · Direct | C Conversion of derivative security | −49,088 0 owned after | $0.00 | 2013-03-27 | |
| 2013-03-25 | CMEA Ventures VI Management, L.P. | Handelsman Karl D. | Watson James F | CMEA Ventures VI GmbH & Co. KG | Collier David J | CMEA VENTURES VI LP | BARUCH THOMAS R | Sohail Faysal A. 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Series A-1 Convertible Participating Preferred Stock Derivative · Direct | C Conversion of derivative security | −2,040,912 0 owned after | $0.00 | 2013-03-27 | |
| 2013-03-25 | CMEA Ventures VI Management, L.P. | Handelsman Karl D. | Watson James F | CMEA Ventures VI GmbH & Co. KG | Collier David J | CMEA VENTURES VI LP | BARUCH THOMAS R | Sohail Faysal A. 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Series A-2 Convertible Participating Preferred Stock Derivative · Direct | C Conversion of derivative security | −64,027 0 owned after | $0.00 | 2013-03-27 | |
| 2013-03-25 | CMEA Ventures VI Management, L.P. | Handelsman Karl D. | Watson James F | CMEA Ventures VI GmbH & Co. KG | Collier David J | CMEA VENTURES VI LP | BARUCH THOMAS R | Sohail Faysal A. 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Series A-2 Convertible Participating Preferred Stock Derivative · Direct | C Conversion of derivative security | −2,662,059 0 owned after | $0.00 | 2013-03-27 | |
| 2013-03-25 | CMEA Ventures VI Management, L.P. | Handelsman Karl D. | Watson James F | CMEA Ventures VI GmbH & Co. KG | Collier David J | CMEA VENTURES VI LP | BARUCH THOMAS R | Sohail Faysal A. 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Series B Convertible Participating Preferred Stock Derivative · Direct | C Conversion of derivative security | −268,269 0 owned after | $0.00 | 2013-03-27 | |
| 2013-03-25 | CMEA Ventures VI Management, L.P. | Handelsman Karl D. | Watson James F | CMEA Ventures VI GmbH & Co. KG | Collier David J | CMEA VENTURES VI LP | BARUCH THOMAS R | Sohail Faysal A. 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Series B Convertible Participating Preferred Stock Derivative · Direct | C Conversion of derivative security | −11,153,776 0 owned after | $0.00 | 2013-03-27 | |
| 2013-03-25 | CMEA Ventures VI Management, L.P. | Handelsman Karl D. | Watson James F | CMEA Ventures VI GmbH & Co. KG | Collier David J | CMEA VENTURES VI LP | BARUCH THOMAS R | Sohail Faysal A. 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Series C Convertible Participating Preferred Stock Derivative · Direct | C Conversion of derivative security | −685,531 0 owned after | $0.00 | 2013-03-27 | |
| 2013-03-25 | CMEA Ventures VI Management, L.P. | Handelsman Karl D. | Watson James F | CMEA Ventures VI GmbH & Co. KG | Collier David J | CMEA VENTURES VI LP | BARUCH THOMAS R | Sohail Faysal A. 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Series C Convertible Participating Preferred Stock Derivative · Direct | C Conversion of derivative security | −28,485,997 0 owned after | $0.00 | 2013-03-27 | |
| 2013-03-25 | Flagship Ventures 2007 General Partner LLC | Flagship Ventures General Partner LLC | KANIA EDWIN M JR | Flagship Ventures Fund 2007, L.P. | Flagship Ventures Fund 2004 L P | AFEYAN NOUBAR 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Series A-1 Convertible Participating Preferred Stock Derivative · Direct | C Conversion of derivative security | −2,090,000 0 owned after | $0.00 | 2013-03-27 | |
| 2013-03-25 | Flagship Ventures 2007 General Partner LLC | Flagship Ventures General Partner LLC | KANIA EDWIN M JR | Flagship Ventures Fund 2007, L.P. | Flagship Ventures Fund 2004 L P | AFEYAN NOUBAR 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Series A-2 Convertible Participating Preferred Stock Derivative · Direct | C Conversion of derivative security | −2,726,088 0 owned after | $0.00 | 2013-03-27 | |
| 2013-03-25 | Flagship Ventures 2007 General Partner LLC | Flagship Ventures General Partner LLC | KANIA EDWIN M JR | Flagship Ventures Fund 2007, L.P. | Flagship Ventures Fund 2004 L P | AFEYAN NOUBAR 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Series B Convertible Participating Preferred Stock Derivative · Direct | C Conversion of derivative security | −11,422,045 0 owned after | $0.00 | 2013-03-27 | |
| 2013-03-25 | Flagship Ventures 2007 General Partner LLC | Flagship Ventures General Partner LLC | KANIA EDWIN M JR | Flagship Ventures Fund 2007, L.P. | Flagship Ventures Fund 2004 L P | AFEYAN NOUBAR 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Series C Convertible Participating Preferred Stock Derivative · Direct | C Conversion of derivative security | −9,626,604 0 owned after | $0.00 | 2013-03-27 | |
| 2013-03-25 | Flagship Ventures 2007 General Partner LLC | Flagship Ventures General Partner LLC | KANIA EDWIN M JR | Flagship Ventures Fund 2007, L.P. | Flagship Ventures Fund 2004 L P | AFEYAN NOUBAR 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Series C Convertible Participating Preferred Stock Derivative · Direct | C Conversion of derivative security | −19,544,924 0 owned after | $0.00 | 2013-03-27 | |
| 2013-03-25 | Trias Joaquim 10% Owner | 4 | Series A-1 Convertible Participating Preferred Stock Derivative · Direct | C Conversion of derivative security | −40,000 0 owned after | $0.00 | 2013-03-27 | |
| 2013-03-25 | Trias Joaquim 10% Owner | 4 | Series A-2 Convertible Participating Preferred Stock Derivative · Direct | C Conversion of derivative security | −52,173 0 owned after | $0.00 | 2013-03-27 | |
| 2013-03-25 | Trias Joaquim 10% Owner | 4 | Series B Convertible Participating Preferred Stock Derivative · Direct | C Conversion of derivative security | −234,000 0 owned after | $0.00 | 2013-03-27 | |
| 2013-03-25 | Trias Joaquim 10% Owner | 4 | Series C Convertible Participating Preferred Stock Derivative · Direct | C Conversion of derivative security | −272,267 0 owned after | $0.00 | 2013-03-27 | |
| 2013-03-25 | Mediphase II LLC | Miller Lawrence G. | Mediphase II (Annex Fund) LLC | Howard Paul Anthony | Mediphase Venture Partners II (Select Fund) Limited Partnership | Mediphase II (Select Fund) LLC | MEDIPHASE VENTURE PARTNERS II LP | Mediphase (DP&UP) LLC | Mediphase Venture Partners II (Annex Fund) Limited Partnership | Mediphase Venture Partners (DP&UP) Limited Partnership 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Series A-1 Convertible Participating Preferred Stock Derivative · Direct | C Conversion of derivative security | −400,000 0 owned after | $0.00 | 2013-03-27 | |
| 2013-03-25 | Mediphase II LLC | Miller Lawrence G. | Mediphase II (Annex Fund) LLC | Howard Paul Anthony | Mediphase Venture Partners II (Select Fund) Limited Partnership | Mediphase II (Select Fund) LLC | MEDIPHASE VENTURE PARTNERS II LP | Mediphase (DP&UP) LLC | Mediphase Venture Partners II (Annex Fund) Limited Partnership | Mediphase Venture Partners (DP&UP) Limited Partnership 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Series A-1 Convertible Participating Preferred Stock Derivative · Direct | C Conversion of derivative security | −400,000 0 owned after | $0.00 | 2013-03-27 | |
| 2013-03-25 | Mediphase II LLC | Miller Lawrence G. | Mediphase II (Annex Fund) LLC | Howard Paul Anthony | Mediphase Venture Partners II (Select Fund) Limited Partnership | Mediphase II (Select Fund) LLC | MEDIPHASE VENTURE PARTNERS II LP | Mediphase (DP&UP) LLC | Mediphase Venture Partners II (Annex Fund) Limited Partnership | Mediphase Venture Partners (DP&UP) Limited Partnership 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Series A-1 Convertible Participating Preferred Stock Derivative · Direct | C Conversion of derivative security | −800,000 0 owned after | $0.00 | 2013-03-27 | |
| 2013-03-25 | Mediphase II LLC | Miller Lawrence G. | Mediphase II (Annex Fund) LLC | Howard Paul Anthony | Mediphase Venture Partners II (Select Fund) Limited Partnership | Mediphase II (Select Fund) LLC | MEDIPHASE VENTURE PARTNERS II LP | Mediphase (DP&UP) LLC | Mediphase Venture Partners II (Annex Fund) Limited Partnership | Mediphase Venture Partners (DP&UP) Limited Partnership 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Series A-2 Convertible Participating Preferred Stock Derivative · Direct | C Conversion of derivative security | −521,739 0 owned after | $0.00 | 2013-03-27 | |
| 2013-03-25 | Mediphase II LLC | Miller Lawrence G. | Mediphase II (Annex Fund) LLC | Howard Paul Anthony | Mediphase Venture Partners II (Select Fund) Limited Partnership | Mediphase II (Select Fund) LLC | MEDIPHASE VENTURE PARTNERS II LP | Mediphase (DP&UP) LLC | Mediphase Venture Partners II (Annex Fund) Limited Partnership | Mediphase Venture Partners (DP&UP) Limited Partnership 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Series A-2 Convertible Participating Preferred Stock Derivative · Direct | C Conversion of derivative security | −521,739 0 owned after | $0.00 | 2013-03-27 | |
| 2013-03-25 | Mediphase II LLC | Miller Lawrence G. | Mediphase II (Annex Fund) LLC | Howard Paul Anthony | Mediphase Venture Partners II (Select Fund) Limited Partnership | Mediphase II (Select Fund) LLC | MEDIPHASE VENTURE PARTNERS II LP | Mediphase (DP&UP) LLC | Mediphase Venture Partners II (Annex Fund) Limited Partnership | Mediphase Venture Partners (DP&UP) Limited Partnership 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Series A-2 Convertible Participating Preferred Stock Derivative · Direct | C Conversion of derivative security | −1,043,478 0 owned after | $0.00 | 2013-03-27 | |
| 2013-03-25 | Mediphase II LLC | Miller Lawrence G. | Mediphase II (Annex Fund) LLC | Howard Paul Anthony | Mediphase Venture Partners II (Select Fund) Limited Partnership | Mediphase II (Select Fund) LLC | MEDIPHASE VENTURE PARTNERS II LP | Mediphase (DP&UP) LLC | Mediphase Venture Partners II (Annex Fund) Limited Partnership | Mediphase Venture Partners (DP&UP) Limited Partnership 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Series B Convertible Participating Preferred Stock Derivative · Direct | C Conversion of derivative security | −2,132,517 0 owned after | $0.00 | 2013-03-27 | |
| 2013-03-25 | Mediphase II LLC | Miller Lawrence G. | Mediphase II (Annex Fund) LLC | Howard Paul Anthony | Mediphase Venture Partners II (Select Fund) Limited Partnership | Mediphase II (Select Fund) LLC | MEDIPHASE VENTURE PARTNERS II LP | Mediphase (DP&UP) LLC | Mediphase Venture Partners II (Annex Fund) Limited Partnership | Mediphase Venture Partners (DP&UP) Limited Partnership 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Series B Convertible Participating Preferred Stock Derivative · Direct | C Conversion of derivative security | −3,096,509 0 owned after | $0.00 | 2013-03-27 | |
| 2013-03-25 | Mediphase II LLC | Miller Lawrence G. | Mediphase II (Annex Fund) LLC | Howard Paul Anthony | Mediphase Venture Partners II (Select Fund) Limited Partnership | Mediphase II (Select Fund) LLC | MEDIPHASE VENTURE PARTNERS II LP | Mediphase (DP&UP) LLC | Mediphase Venture Partners II (Annex Fund) Limited Partnership | Mediphase Venture Partners (DP&UP) Limited Partnership 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Series B Convertible Participating Preferred Stock Derivative · Direct | C Conversion of derivative security | −6,193,019 0 owned after | $0.00 | 2013-03-27 | |
| 2013-03-25 | Mediphase II LLC | Miller Lawrence G. | Mediphase II (Annex Fund) LLC | Howard Paul Anthony | Mediphase Venture Partners II (Select Fund) Limited Partnership | Mediphase II (Select Fund) LLC | MEDIPHASE VENTURE PARTNERS II LP | Mediphase (DP&UP) LLC | Mediphase Venture Partners II (Annex Fund) Limited Partnership | Mediphase Venture Partners (DP&UP) Limited Partnership 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Series C Convertible Participating Preferred Stock Derivative · Direct | C Conversion of derivative security | −9,101,517 0 owned after | $0.00 | 2013-03-27 | |
| 2013-03-25 | Mediphase II LLC | Miller Lawrence G. | Mediphase II (Annex Fund) LLC | Howard Paul Anthony | Mediphase Venture Partners II (Select Fund) Limited Partnership | Mediphase II (Select Fund) LLC | MEDIPHASE VENTURE PARTNERS II LP | Mediphase (DP&UP) LLC | Mediphase Venture Partners II (Annex Fund) Limited Partnership | Mediphase Venture Partners (DP&UP) Limited Partnership 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Series C Convertible Participating Preferred Stock Derivative · Direct | C Conversion of derivative security | −2,761,571 0 owned after | $0.00 | 2013-03-27 | |
| 2013-03-25 | Mediphase II LLC | Miller Lawrence G. | Mediphase II (Annex Fund) LLC | Howard Paul Anthony | Mediphase Venture Partners II (Select Fund) Limited Partnership | Mediphase II (Select Fund) LLC | MEDIPHASE VENTURE PARTNERS II LP | Mediphase (DP&UP) LLC | Mediphase Venture Partners II (Annex Fund) Limited Partnership | Mediphase Venture Partners (DP&UP) Limited Partnership 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Series C Convertible Participating Preferred Stock Derivative · Direct | C Conversion of derivative security | −8,556,982 0 owned after | $0.00 | 2013-03-27 | |
| 2013-03-25 | Mediphase II LLC | Miller Lawrence G. | Mediphase II (Annex Fund) LLC | Howard Paul Anthony | Mediphase Venture Partners II (Select Fund) Limited Partnership | Mediphase II (Select Fund) LLC | MEDIPHASE VENTURE PARTNERS II LP | Mediphase (DP&UP) LLC | Mediphase Venture Partners II (Annex Fund) Limited Partnership | Mediphase Venture Partners (DP&UP) Limited Partnership 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Series C Convertible Participating Preferred Stock Derivative · Direct | C Conversion of derivative security | −2,917,152 0 owned after | $0.00 | 2013-03-27 | |
| 2013-03-25 | Petrillo Enrico | Enriquez Juan | Excel Medical Ventures, LLC | EXCEL MEDICAL FUND LP | Blume Frederick R. 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Series C Convertible Participating Preferred Stock Derivative · Direct | C Conversion of derivative security | −28,199,144 0 owned after | $0.00 | 2013-03-27 | |
| 2013-03-25 | KANEKO YASUNORI | Skyline Venture Management IV, LLC | Skyline Venture Partners Qualified Purchaser Fund IV L P 10% Owner | 10% Owner | 10% Owner | 4 | Series A-1 Convertible Participating Preferred Stock Derivative · Direct | C Conversion of derivative security | −2,090,000 0 owned after | $0.00 | 2013-03-27 | |
| 2013-03-25 | KANEKO YASUNORI | Skyline Venture Management IV, LLC | Skyline Venture Partners Qualified Purchaser Fund IV L P 10% Owner | 10% Owner | 10% Owner | 4 | Series A-2 Convertible Participating Preferred Stock Derivative · Direct | C Conversion of derivative security | −2,726,086 0 owned after | $0.00 | 2013-03-27 | |
| 2013-03-25 | KANEKO YASUNORI | Skyline Venture Management IV, LLC | Skyline Venture Partners Qualified Purchaser Fund IV L P 10% Owner | 10% Owner | 10% Owner | 4 | Series B Convertible Participating Preferred Stock Derivative · Direct | C Conversion of derivative security | −11,422,045 0 owned after | $0.00 | 2013-03-27 | |
| 2013-03-25 | KANEKO YASUNORI | Skyline Venture Management IV, LLC | Skyline Venture Partners Qualified Purchaser Fund IV L P 10% Owner | 10% Owner | 10% Owner | 4 | Series C Convertible Participating Preferred Stock Derivative · Direct | C Conversion of derivative security | −27,226,760 0 owned after | $0.00 | 2013-03-27 | |
| 2013-03-25 | Freund John Gordon Director, 10% Owner | 4 | Series A-1 Convertible Participating Preferred Stock Derivative · Indirect · (m) | C Conversion of derivative security | −2,090,000 0 owned after | $0.00 | 2013-03-27 | |
| 2013-03-25 | Freund John Gordon Director, 10% Owner | 4 | Series A-2 Convertible Participating Preferred Stock Derivative · Indirect · (m) | C Conversion of derivative security | −2,726,086 0 owned after | $0.00 | 2013-03-27 | |
| 2013-03-25 | Freund John Gordon Director, 10% Owner | 4 | Series B Convertible Participating Preferred Stock Derivative · Indirect · (m) | C Conversion of derivative security | −11,422,045 0 owned after | $0.00 | 2013-03-27 | |
| 2013-03-25 | Freund John Gordon Director, 10% Owner | 4 | Series C Convertible Participating Preferred Stock Derivative · Indirect · (m) | C Conversion of derivative security | −27,226,760 0 owned after | $0.00 | 2013-03-27 | |
| 2013-03-25 | Gullans Steven R. Ph.D. Director, 10% Owner | 4 | Series C Convertible Participating Preferred Stock Derivative · Indirect · (m) | C Conversion of derivative security | −28,199,144 0 owned after | $0.00 | 2013-03-27 | |
| 2013-03-25 | Lubner David Charles Officer (SVP and CFO), 10% Owner | 4 | Series A-1 Convertible Participating Preferred Stock Derivative · Direct | C Conversion of derivative security | −40,000 0 owned after | $0.00 | 2013-03-27 | |
| 2013-03-25 | Lubner David Charles Officer (SVP and CFO), 10% Owner | 4 | Series A-2 Convertible Participating Preferred Stock Derivative · Direct | C Conversion of derivative security | −52,173 0 owned after | $0.00 | 2013-03-27 | |
| 2013-03-25 | Lubner David Charles Officer (SVP and CFO), 10% Owner | 4 | Series B Convertible Participating Preferred Stock Derivative · Direct | C Conversion of derivative security | −115,000 0 owned after | $0.00 | 2013-03-27 | |
| 2013-03-25 | Lubner David Charles Officer (SVP and CFO), 10% Owner | 4 | Series C Convertible Participating Preferred Stock Derivative · Direct | C Conversion of derivative security | −116,686 0 owned after | $0.00 | 2013-03-27 | |
| 2013-03-25 | FMR LLC | 4 | Series A-1 Convertible Preferred Stock Derivative · Indirect · by Beacon Bioventures Limited Partnership | C Conversion of derivative security | −2,075,931 0 owned after | no price filed | 2013-03-27 | |
| 2013-03-25 | FMR LLC | 4 | Series A-2 Convertible Preferred Stock Derivative · Indirect · by Beacon Bioventures Limited Partnership | C Conversion of derivative security | −2,707,735 0 owned after | no price filed | 2013-03-27 | |
| 2013-03-25 | FMR LLC | 4 | Series B Convertible Preferred Stock Derivative · Indirect · by Beacon Bioventures Limited Partnership | C Conversion of derivative security | −11,345,154 0 owned after | no price filed | 2013-03-27 | |
| 2013-03-25 | FMR LLC | 4 | Series C Convertible Preferred Stock Derivative · Indirect · by Beacon Bioventures Limited Partnership | C Conversion of derivative security | −27,043,477 0 owned after | no price filed | 2013-03-27 | |
| 2013-03-25 | FMR LLC | 4 | Series A-1 Convertible Preferred Stock Derivative · Indirect · by Beacon Bioventures Principals Limited Partnership | C Conversion of derivative security | −14,069 0 owned after | no price filed | 2013-03-27 | |
| 2013-03-25 | FMR LLC | 4 | Series A-2 Convertible Preferred Stock Derivative · Indirect · by Beacon Bioventures Principals Limited Partnership | C Conversion of derivative security | −18,351 0 owned after | no price filed | 2013-03-27 | |
| 2013-03-25 | FMR LLC | 4 | Series B Convertible Preferred Stock Derivative · Indirect · by Beacon Bioventures Principals Limited Partnership | C Conversion of derivative security | −76,891 0 owned after | no price filed | 2013-03-27 | |
| 2013-03-25 | FMR LLC | 4 | Series C Convertible Preferred Stock Derivative · Indirect · by Beacon Bioventures Principals Limited Partnership | C Conversion of derivative security | −183,283 0 owned after | no price filed | 2013-03-27 | |
| 2013-03-19 holding as of filing | Xiao Xiao-Yi 10% Owner | 3 | Series B Convertible Participating Preferred Stock Derivative · Direct | Holding | no price filed | 2013-03-19 | ||
| 2013-03-19 holding as of filing | AFEYAN NOUBAR | Flagship Ventures Fund 2007, L.P. | Flagship Ventures 2007 General Partner LLC | Flagship Ventures Fund 2004 L P | KANIA EDWIN M JR | Flagship Ventures General Partner LLC 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 3 | Series A-1 Convertible Participating Preferred Stock Derivative · Direct | Holding | no price filed | 2013-03-19 | ||
| 2013-03-19 holding as of filing | AFEYAN NOUBAR | Flagship Ventures Fund 2007, L.P. | Flagship Ventures 2007 General Partner LLC | Flagship Ventures Fund 2004 L P | KANIA EDWIN M JR | Flagship Ventures General Partner LLC 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 3 | Series A-2 Convertible Participating Preferred Stock Derivative · Direct | Holding | no price filed | 2013-03-19 | ||
| 2013-03-19 holding as of filing | AFEYAN NOUBAR | Flagship Ventures Fund 2007, L.P. | Flagship Ventures 2007 General Partner LLC | Flagship Ventures Fund 2004 L P | KANIA EDWIN M JR | Flagship Ventures General Partner LLC 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 3 | Series B Convertible Participating Preferred Stock Derivative · Direct | Holding | no price filed | 2013-03-19 | ||
| 2013-03-19 holding as of filing | AFEYAN NOUBAR | Flagship Ventures Fund 2007, L.P. | Flagship Ventures 2007 General Partner LLC | Flagship Ventures Fund 2004 L P | KANIA EDWIN M JR | Flagship Ventures General Partner LLC 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 3 | Series C Convertible Participating Preferred Stock Derivative · Direct | Holding | no price filed | 2013-03-19 | ||
| 2013-03-19 holding as of filing | AFEYAN NOUBAR | Flagship Ventures Fund 2007, L.P. | Flagship Ventures 2007 General Partner LLC | Flagship Ventures Fund 2004 L P | KANIA EDWIN M JR | Flagship Ventures General Partner LLC 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 3 | Series C Convertible Participating Preferred Stock Derivative · Direct | Holding | no price filed | 2013-03-19 | ||
| 2013-03-19 holding as of filing | Sohail Faysal A. | Collier David J | Handelsman Karl D. | CMEA Ventures VI GmbH & Co. KG | CMEA Ventures VI Management, L.P. | CMEA VENTURES VI LP | BARUCH THOMAS R | Watson James F 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 3 | Series A-1 Convertible Participating Preferred Derivative · Direct | Holding | no price filed | 2013-03-19 | ||
| 2013-03-19 holding as of filing | Sohail Faysal A. | Collier David J | Handelsman Karl D. | CMEA Ventures VI GmbH & Co. KG | CMEA Ventures VI Management, L.P. | CMEA VENTURES VI LP | BARUCH THOMAS R | Watson James F 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 3 | Series A-1 Convertible Participating Preferred Derivative · Direct | Holding | no price filed | 2013-03-19 | ||
| 2013-03-19 holding as of filing | Sohail Faysal A. | Collier David J | Handelsman Karl D. | CMEA Ventures VI GmbH & Co. KG | CMEA Ventures VI Management, L.P. | CMEA VENTURES VI LP | BARUCH THOMAS R | Watson James F 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 3 | Series A-2 Convertible Participating Preferred Derivative · Direct | Holding | no price filed | 2013-03-19 | ||
| 2013-03-19 holding as of filing | Sohail Faysal A. | Collier David J | Handelsman Karl D. | CMEA Ventures VI GmbH & Co. KG | CMEA Ventures VI Management, L.P. | CMEA VENTURES VI LP | BARUCH THOMAS R | Watson James F 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 3 | Series A-2 Convertible Participating Preferred Derivative · Direct | Holding | no price filed | 2013-03-19 | ||
| 2013-03-19 holding as of filing | Sohail Faysal A. | Collier David J | Handelsman Karl D. | CMEA Ventures VI GmbH & Co. KG | CMEA Ventures VI Management, L.P. | CMEA VENTURES VI LP | BARUCH THOMAS R | Watson James F 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 3 | Series B Convertible Participating Preferred Derivative · Direct | Holding | no price filed | 2013-03-19 | ||
| 2013-03-19 holding as of filing | Sohail Faysal A. | Collier David J | Handelsman Karl D. | CMEA Ventures VI GmbH & Co. KG | CMEA Ventures VI Management, L.P. | CMEA VENTURES VI LP | BARUCH THOMAS R | Watson James F 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 3 | Series B Convertible Participating Preferred Derivative · Direct | Holding | no price filed | 2013-03-19 | ||
| 2013-03-19 holding as of filing | Sohail Faysal A. | Collier David J | Handelsman Karl D. | CMEA Ventures VI GmbH & Co. KG | CMEA Ventures VI Management, L.P. | CMEA VENTURES VI LP | BARUCH THOMAS R | Watson James F 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 3 | Series C Convertible Participating Preferred Derivative · Direct | Holding | no price filed | 2013-03-19 | ||
| 2013-03-19 holding as of filing | Sohail Faysal A. | Collier David J | Handelsman Karl D. | CMEA Ventures VI GmbH & Co. KG | CMEA Ventures VI Management, L.P. | CMEA VENTURES VI LP | BARUCH THOMAS R | Watson James F 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 3 | Series C Convertible Participating Preferred Derivative · Direct | Holding | no price filed | 2013-03-19 | ||
| 2013-03-19 holding as of filing | Trias Joaquim 10% Owner | 3 | Series A-1 Convertible Participating Preferred Stock Derivative · Direct | Holding | no price filed | 2013-03-19 | ||
| 2013-03-19 holding as of filing | Trias Joaquim 10% Owner | 3 | Series A-2 Convertible Participating Preferred Stock Derivative · Direct | Holding | no price filed | 2013-03-19 | ||
| 2013-03-19 holding as of filing | Trias Joaquim 10% Owner | 3 | Series B Convertible Participating Preferred Stock Derivative · Direct | Holding | no price filed | 2013-03-19 | ||
| 2013-03-19 holding as of filing | Trias Joaquim 10% Owner | 3 | Series C Convertible Participating Preferred Stock Derivative · Direct | Holding | no price filed | 2013-03-19 | ||
| 2013-03-19 holding as of filing | Petrillo Enrico | EXCEL MEDICAL FUND LP | Excel Medical Ventures, LLC | Blume Frederick R. | Enriquez Juan 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 3 | Series C Convertible Participating Preferred Stock Derivative · Direct | Holding | no price filed | 2013-03-19 | ||
| 2013-03-19 holding as of filing | Freund John Gordon Director, 10% Owner | 3 | Series A-1 Convertible Participating Preferred Stock Derivative · Indirect · By Skyline Venture Partners Qualified Purchaser IV L.P. | Holding | no price filed | 2013-03-19 | ||
| 2013-03-19 holding as of filing | Freund John Gordon Director, 10% Owner | 3 | Series A-2 Convertible Participating Preferred Stock Derivative · Indirect · By Skyline Venture Partners Qualified Purchaser IV L.P. | Holding | no price filed | 2013-03-19 | ||
| 2013-03-19 holding as of filing | Freund John Gordon Director, 10% Owner | 3 | Series B Convertible Participating Preferred Stock Derivative · Indirect · By Skyline Venture Partners Qualified Purchaser IV L.P. | Holding | no price filed | 2013-03-19 | ||
| 2013-03-19 holding as of filing | Freund John Gordon Director, 10% Owner | 3 | Series C Convertible Participating Preferred Stock Derivative · Indirect · By Skyline Venture Partners Qualified Purchaser IV L.P | Holding | no price filed | 2013-03-19 | ||
| 2013-03-19 holding as of filing | Skyline Venture Partners Qualified Purchaser Fund IV L P | Skyline Venture Management IV, LLC | KANEKO YASUNORI 10% Owner | 10% Owner | 10% Owner | 3 | Series A-1 Convertible Participating preferred Stock Derivative · Direct | Holding | no price filed | 2013-03-19 | ||
| 2013-03-19 holding as of filing | Skyline Venture Partners Qualified Purchaser Fund IV L P | Skyline Venture Management IV, LLC | KANEKO YASUNORI 10% Owner | 10% Owner | 10% Owner | 3 | Series A-2 Convertible Participating preferred Stock Derivative · Direct | Holding | no price filed | 2013-03-19 | ||
| 2013-03-19 holding as of filing | Skyline Venture Partners Qualified Purchaser Fund IV L P | Skyline Venture Management IV, LLC | KANEKO YASUNORI 10% Owner | 10% Owner | 10% Owner | 3 | Series B Convertible Participating preferred Stock Derivative · Direct | Holding | no price filed | 2013-03-19 | ||
| 2013-03-19 holding as of filing | Skyline Venture Partners Qualified Purchaser Fund IV L P | Skyline Venture Management IV, LLC | KANEKO YASUNORI 10% Owner | 10% Owner | 10% Owner | 3 | Series C Convertible Participating preferred Stock Derivative · Direct | Holding | no price filed | 2013-03-19 | ||
| 2013-03-19 holding as of filing | Gullans Steven R. Ph.D. Director, 10% Owner | 3 | Series C Convertible Participating Preferred Stock Derivative · Indirect · By Excel Medical Fund, L.P. | Holding | no price filed | 2013-03-19 | ||
| 2013-03-19 holding as of filing | Mediphase Venture Partners II (Annex Fund) Limited Partnership | Mediphase II LLC | Miller Lawrence G. | MEDIPHASE VENTURE PARTNERS II LP | Mediphase Venture Partners II (Select Fund) Limited Partnership | Mediphase (DP&UP) LLC | Howard Paul Anthony | Mediphase Venture Partners (DP&UP) Limited Partnership | Mediphase II (Select Fund) LLC | Mediphase II (Annex Fund) LLC 10% Owner | 10% Owner | 10% Owner | Director, 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 3 | Series A-1 Convertible Participating Preferred Stock Derivative · Direct | Holding | no price filed | 2013-03-19 | ||
| 2013-03-19 holding as of filing | Mediphase Venture Partners II (Annex Fund) Limited Partnership | Mediphase II LLC | Miller Lawrence G. | MEDIPHASE VENTURE PARTNERS II LP | Mediphase Venture Partners II (Select Fund) Limited Partnership | Mediphase (DP&UP) LLC | Howard Paul Anthony | Mediphase Venture Partners (DP&UP) Limited Partnership | Mediphase II (Select Fund) LLC | Mediphase II (Annex Fund) LLC 10% Owner | 10% Owner | 10% Owner | Director, 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 3 | Series A-1 Convertible Participating Preferred Stock Derivative · Direct | Holding | no price filed | 2013-03-19 | ||
| 2013-03-19 holding as of filing | Mediphase Venture Partners II (Annex Fund) Limited Partnership | Mediphase II LLC | Miller Lawrence G. | MEDIPHASE VENTURE PARTNERS II LP | Mediphase Venture Partners II (Select Fund) Limited Partnership | Mediphase (DP&UP) LLC | Howard Paul Anthony | Mediphase Venture Partners (DP&UP) Limited Partnership | Mediphase II (Select Fund) LLC | Mediphase II (Annex Fund) LLC 10% Owner | 10% Owner | 10% Owner | Director, 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 3 | Series A-1 Convertible Participating Preferred Stock Derivative · Direct | Holding | no price filed | 2013-03-19 | ||
| 2013-03-19 holding as of filing | Mediphase Venture Partners II (Annex Fund) Limited Partnership | Mediphase II LLC | Miller Lawrence G. | MEDIPHASE VENTURE PARTNERS II LP | Mediphase Venture Partners II (Select Fund) Limited Partnership | Mediphase (DP&UP) LLC | Howard Paul Anthony | Mediphase Venture Partners (DP&UP) Limited Partnership | Mediphase II (Select Fund) LLC | Mediphase II (Annex Fund) LLC 10% Owner | 10% Owner | 10% Owner | Director, 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 3 | Series A-2 Convertible Participating Preferred Stock Derivative · Direct | Holding | no price filed | 2013-03-19 | ||
| 2013-03-19 holding as of filing | Mediphase Venture Partners II (Annex Fund) Limited Partnership | Mediphase II LLC | Miller Lawrence G. | MEDIPHASE VENTURE PARTNERS II LP | Mediphase Venture Partners II (Select Fund) Limited Partnership | Mediphase (DP&UP) LLC | Howard Paul Anthony | Mediphase Venture Partners (DP&UP) Limited Partnership | Mediphase II (Select Fund) LLC | Mediphase II (Annex Fund) LLC 10% Owner | 10% Owner | 10% Owner | Director, 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 3 | Series A-2 Convertible Participating Preferred Stock Derivative · Direct | Holding | no price filed | 2013-03-19 | ||
| 2013-03-19 holding as of filing | Mediphase Venture Partners II (Annex Fund) Limited Partnership | Mediphase II LLC | Miller Lawrence G. | MEDIPHASE VENTURE PARTNERS II LP | Mediphase Venture Partners II (Select Fund) Limited Partnership | Mediphase (DP&UP) LLC | Howard Paul Anthony | Mediphase Venture Partners (DP&UP) Limited Partnership | Mediphase II (Select Fund) LLC | Mediphase II (Annex Fund) LLC 10% Owner | 10% Owner | 10% Owner | Director, 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 3 | Series A-2 Convertible Participating Preferred Stock Derivative · Direct | Holding | no price filed | 2013-03-19 | ||
| 2013-03-19 holding as of filing | Mediphase Venture Partners II (Annex Fund) Limited Partnership | Mediphase II LLC | Miller Lawrence G. | MEDIPHASE VENTURE PARTNERS II LP | Mediphase Venture Partners II (Select Fund) Limited Partnership | Mediphase (DP&UP) LLC | Howard Paul Anthony | Mediphase Venture Partners (DP&UP) Limited Partnership | Mediphase II (Select Fund) LLC | Mediphase II (Annex Fund) LLC 10% Owner | 10% Owner | 10% Owner | Director, 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 3 | Series B Convertible Participating Preferred Stock Derivative · Direct | Holding | no price filed | 2013-03-19 | ||
| 2013-03-19 holding as of filing | Mediphase Venture Partners II (Annex Fund) Limited Partnership | Mediphase II LLC | Miller Lawrence G. | MEDIPHASE VENTURE PARTNERS II LP | Mediphase Venture Partners II (Select Fund) Limited Partnership | Mediphase (DP&UP) LLC | Howard Paul Anthony | Mediphase Venture Partners (DP&UP) Limited Partnership | Mediphase II (Select Fund) LLC | Mediphase II (Annex Fund) LLC 10% Owner | 10% Owner | 10% Owner | Director, 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 3 | Series B Convertible Participating Preferred Stock Derivative · Direct | Holding | no price filed | 2013-03-19 | ||
| 2013-03-19 holding as of filing | Mediphase Venture Partners II (Annex Fund) Limited Partnership | Mediphase II LLC | Miller Lawrence G. | MEDIPHASE VENTURE PARTNERS II LP | Mediphase Venture Partners II (Select Fund) Limited Partnership | Mediphase (DP&UP) LLC | Howard Paul Anthony | Mediphase Venture Partners (DP&UP) Limited Partnership | Mediphase II (Select Fund) LLC | Mediphase II (Annex Fund) LLC 10% Owner | 10% Owner | 10% Owner | Director, 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 3 | Series B Convertible Participating Preferred Stock Derivative · Direct | Holding | no price filed | 2013-03-19 | ||
| 2013-03-19 holding as of filing | Mediphase Venture Partners II (Annex Fund) Limited Partnership | Mediphase II LLC | Miller Lawrence G. | MEDIPHASE VENTURE PARTNERS II LP | Mediphase Venture Partners II (Select Fund) Limited Partnership | Mediphase (DP&UP) LLC | Howard Paul Anthony | Mediphase Venture Partners (DP&UP) Limited Partnership | Mediphase II (Select Fund) LLC | Mediphase II (Annex Fund) LLC 10% Owner | 10% Owner | 10% Owner | Director, 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 3 | Series C Convertible Participating Preferred Stock Derivative · Direct | Holding | no price filed | 2013-03-19 | ||
| 2013-03-19 holding as of filing | Mediphase Venture Partners II (Annex Fund) Limited Partnership | Mediphase II LLC | Miller Lawrence G. | MEDIPHASE VENTURE PARTNERS II LP | Mediphase Venture Partners II (Select Fund) Limited Partnership | Mediphase (DP&UP) LLC | Howard Paul Anthony | Mediphase Venture Partners (DP&UP) Limited Partnership | Mediphase II (Select Fund) LLC | Mediphase II (Annex Fund) LLC 10% Owner | 10% Owner | 10% Owner | Director, 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 3 | Series C Convertible Participating Preferred Stock Derivative · Direct | Holding | no price filed | 2013-03-19 | ||
| 2013-03-19 holding as of filing | Mediphase Venture Partners II (Annex Fund) Limited Partnership | Mediphase II LLC | Miller Lawrence G. | MEDIPHASE VENTURE PARTNERS II LP | Mediphase Venture Partners II (Select Fund) Limited Partnership | Mediphase (DP&UP) LLC | Howard Paul Anthony | Mediphase Venture Partners (DP&UP) Limited Partnership | Mediphase II (Select Fund) LLC | Mediphase II (Annex Fund) LLC 10% Owner | 10% Owner | 10% Owner | Director, 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 3 | Series C Convertible Participating Preferred Stock Derivative · Direct | Holding | no price filed | 2013-03-19 | ||
| 2013-03-19 holding as of filing | Mediphase Venture Partners II (Annex Fund) Limited Partnership | Mediphase II LLC | Miller Lawrence G. | MEDIPHASE VENTURE PARTNERS II LP | Mediphase Venture Partners II (Select Fund) Limited Partnership | Mediphase (DP&UP) LLC | Howard Paul Anthony | Mediphase Venture Partners (DP&UP) Limited Partnership | Mediphase II (Select Fund) LLC | Mediphase II (Annex Fund) LLC 10% Owner | 10% Owner | 10% Owner | Director, 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 3 | Series C Convertible Participating Preferred Stock Derivative · Direct | Holding | no price filed | 2013-03-19 | ||
| 2013-03-19 holding as of filing | Lubner David Charles Officer (SVP and CFO), 10% Owner | 3 | Series A-1 Convertible Participating Preferred Stock Derivative · Direct | Holding | no price filed | 2013-03-19 | ||
| 2013-03-19 holding as of filing | Lubner David Charles Officer (SVP and CFO), 10% Owner | 3 | Series A-2 Convertible Participating Preferred Stock Derivative · Direct | Holding | no price filed | 2013-03-19 | ||
| 2013-03-19 holding as of filing | Lubner David Charles Officer (SVP and CFO), 10% Owner | 3 | Series B Convertible Participating Preferred Stock Derivative · Direct | Holding | no price filed | 2013-03-19 | ||
| 2013-03-19 holding as of filing | Lubner David Charles Officer (SVP and CFO), 10% Owner | 3 | Series C Convertible Participating Preferred Stock Derivative · Direct | Holding | no price filed | 2013-03-19 | ||
| 2013-03-19 holding as of filing | FMR LLC | 3 | Series A-1 Convertible Preferred Stock Derivative · Indirect · by Beacon Bioventures Limited Partnership | Holding | no price filed | 2013-03-19 | ||
| 2013-03-19 holding as of filing | FMR LLC | 3 | Series A-2 Convertible Preferred Stock Derivative · Indirect · by Beacon Bioventures Limited Partnership | Holding | no price filed | 2013-03-19 | ||
| 2013-03-19 holding as of filing | FMR LLC | 3 | Series B Convertible Preferred Stock Derivative · Indirect · by Beacon Bioventures Limited Partnership | Holding | no price filed | 2013-03-19 |